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Classification	of	Foreign	Body	Reactions	due	to	Industrial	
Silicone	Injection	
A foreign body reaction (FBR) is a typical tissue response
to a biomaterial that has been injected or implanted in
human body tissue. There has been a lack of data on the
classification of foreign body reaction to silicone injection,
which can describe the pattern of body tissue responses
to silicone.
We modified the classification proposed by Duranti and colleagues,
which has categorized a FBR to hyaluronic acid injection into a new
classification of an FBR to silicone injection. A cohort study of 31
women suffering from silicone-induced granulomas on their chin was
conducted. Granulomatous tissue and sub- mental skin were stained
with hematoxylineosin and evaluated.
Background METHOD
Histopathological examination showed 8 categories of
FBRs because of silicone injection. Those categories
could be split into the following 7 stages without
Category 1: Stage 1 (Category 2), mild reaction with
few inflammatory cells; Stage 2 (Category 3),
inflammatory cells with one or 2 giant cells; Stage 3
(Category 4), inflammatory cells with more than 2 giant
cells and <50% of the area undergoing fibrosis; Stage 4
(Category 5), inflammatory cells with more than 2 giant
cells and >50% of the area undergoing fibrosis; Stage 5
(Category 6), inflammatory cells with one giant cell and
>50% of the area undergoing fibrosis; and Stage 6
(Category 7), <50% of the area now fibrotic with no
giant cells; Stage 7 (Category 8), >50% of the area now
fibrotic with no giant cells.
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Using	histopathological	staining,	we	are	able	to	
sequence	the	steps	of	body	reactions	to	silicone	
injection.	Initial	inflammatory	reaction	is	then	
replaced	by	fibrosis	process	repairing	the	damaged	tis-
sues.	The	process	depends	on	the	host	immune	
tolerance.	
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Figure	1. Categories	of	foreign	body	reactions	to	injected	silicone.	
Table	1. Clinical	Examination,	Onset	of	Granuloma	Symptoms,	and	Silicone	
Concentration	for	Subjects	of	Different	Age	Categories	
TABLE	2.	Categories	of	Histopathology	Examination	in	
the	Normal,	Granuloma,	and	Submental Skin	Group	
TABLE	3.	Comparison	of	Histopathology	
Between	the	Granuloma	and	Submental Skin	
Group	
Category 1: No visible reaction. Category 2:
Mild reaction with a few inflammatory
cells. Category 3: Inflammatory cells and
one or 2 giant cells. Category 4: Inflam-
matory cells and more than 2 giant cells.
Less than 50% of the area is fibrotic.
Category 5: Inflammatory cells and more
than 2 giant cells. Less than 50% of the
area is fibrotic. Category 6: Inflammatory
cells and one giant cell. Less than 50% of
the area is fibrotic. Category 7: Less than
50% of the area is fibrotic. No giant cells.
Category 8: Less than 50% of the area is
fibrotic. No giant cells.
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Introduction  
Silicone injection has been used since 40 years ago and at that time, many 
problems occurred such as migration, inflammation, and granuloma. In 1992, FDA 
prohibited silicone injection for cosmetic use.1 In addition to injection silicone may be 
introduced into our body or skin through food intake and cosmetic. Silicone has been 
widely used in daily cosmetics. Nowadays, due to technology advances, topical drugs 
can pass through skin barrier and can be penetrated into the skin, which has become 
a great concern as it may induce granuloma formation. There are relatively very few 
studies have been done on silicone concentration in normal skin.  
A study conducted by A Harlim in 2018 found that normal skin contained 
silicone. The study was performed by taking skin samples from normal subjects and 
those with face-lift procedure and subsequently compared those samples using the 
same criteria with the control group, which included skin samples of subjects that had 
received silicone injection and the study found granuloma formation. The study found 
an average amount of silicone level of 44.07±75.86 µg/g in patients with normal skin; 
while in patients with granuloma, they found 38 times greater silicone level 
(1709.21±1851.72 µg/g).2 
 
Silicone  
Injectable-grade silicone for medical use has been manufactured widely since 
the element has been known for its stable and inert characteristics.5,6 It includes the 
use of silicone oil, which has been utilized in the treatment of complicated retinal 
detachment and heavy silicone oil tamponade. The treatment seems to offer promising 
results, particularly on improving visual acuity as well as great results on some 
anatomical parameters; however, there are some concerns as it may cause several 
complications such as cataract, increased ocular pressure, heavy silicon oil 
emulsification and mild inflammatory reaction.7-9 
Injectable-grade slicione has also been widely used in the form of silicone oil 
injection. Some studies have suggested that it may have an essential role in reducing 
the risk of developing diabetic foot ulcer due to its pressure-reducing properties; 
therefore, it can maintain plantar tissue thickness and alleviate symptoms of diabetic 
foot ulcer, which may be associated with foot biomechanics.10,13  
Although it brings advantages, silicone injection may still develop some 
complications, either local or systemic complications. Local complications may 
include formation of palpable nodule surrounding injection site, arthralgia, fatigue, 
electrical neuropathy and electrical sensation;14 while systemic complications may also 
occur in the form of lymphadenopathy, renal disease and hepatic disease. It indicates 
that the injected silicone can migrate from injection site to other organ causing local 
and systemic complications. An animal experimental study in mice model may explain 
the pathogenesis of such complications. The study has demonstrated that macrophage 
of skin tissue may engulf the injected silicone and the silicone may be distributed 
through lymphatic circulation and ultimately causing accumulation in lymph nodes, 
adrenal glands, kidney, liver and spleen as well as granuloma formation in the skin.15 
Complications due to silicone injection, particularly the granuloma formation may be 
dose-dependent. A study by A Harlim has demonstrated that granuloma formation 
could be developed when there is a large amount of silicone exposure as the study only 
found a low level of silicone without any granuloma formation in normal skin.2  
 
Figure 1. The level of silicon (Si) in normal subjects who had never received silicone injection (never 
injected) and in subjects with granuloma who had received silicone injection (injected)  
  
Cultural changes have been encouraging people to pursue their passion on beauty and 
youth; therefore, cosmeticology has been rapidly growing. With technological 
advances, more mixed drug ingredients have been added to cosmetic products in order 
to beautify their customers. Thus, it may indirectly increase the use of topical 
cosmetics that usually contain silicone; therefore, it will lead to increase silicone 
uptake to the skin. It has raised a concern that prolonged and continuous use of 
cosmectics will cause granuloma formation and other chronic inflammatory effects.  
Dietary intake and silicon 
Aside from medical use, silicon has also been used in food industry, cosmectics 
and pharmaceutical industries. Our data shows that the silicon levels in 
gastrointestinal medications (e.g. antacids), mineral water and soda drinks are 44.1, 
25.6, 2.91 µg/g, respectively. It can be said that there are many routes for 
administering silicon into our body. The average daily intake of silicon for European 
and North American populations is 20-50 mg/day. In China and India, the daily intake 
of silicon is larger that may reach as many as 140-200 mg/day, in which wheats, fruits 
and vegetables are the greatest producers.3 
A research institution of healthy aging and nutrition in U.K. has recently 
reported a strong correlation between silicon in dietary intake and the health of bone 
and connective tissue. Therefore, it can be assumed that the correlation is associated 
with collagen synthesis and/or stabilization of mineral matrix, i.e. silicone intake may 
affect bone density.4 
Another study, which is an animal experimental study, has demonstrated that 
there is no evidence of silicon accumulation in silicon consumption. Silicon can be 
eliminated through digestion process and can be found feces (93-97%), urine (0.001-
0.22%) and expired air (0.01-0.02%).5 It indicates that silicon is a stable element and 
at certain degree it can be resistant to digestive enzymes including gastric acid; 
therefore, it seems that silicon is not accumulated in the gastroinstestinal system.  
Silicon in Cosmetics 
Beauty products for face, hair, and cosmetics may have high silicon content, in 
which it will be accumulated in the skin tissue. When a topical beauty product 
containing silicon is applied to the skin, the elastrometic particles of silicon will absorb 
various liquids including emollient and oil; therefore, silicon is used in skin care 
product as vehicle (carrier) of active ingredient for the skin or as oil control product of 
the skin.6,7 
Types of silicone that are commonly used in cosmetic products:  • Dimethicone – clear, inert, liquid solubility depends on the length of  polymer 
backbone ranging in thickness from watery consistency to thick.   
• Dimethicone Copolyol – silicone that contains an –OH group; therefore it is 
more water soluble resulting in easier incorporation into water-based 
formulations and also reduces the “slip effect” of the silicone  • Cyclomethicone – the shortest cyclic molecule, which has many similarities 
with dimethicone except it can evaporate; while dimethicone can not. • Cyclo-Dimethicone – a combination of dimethicone dan cyclomethicones. 
The great use of silicones in cosmetic product may increase the risk of 
accumulation of the substance in our body, particularly in facial skin. No clear 
evidence has been found on the bioavailability and concentration of accumulated 
silicone in topical uses.  
Granuloma: Definition  
Granuloma is a foreign body reaction against foreign substances that enter the skin. 
Granuloma occurs due to continuous or chronic inflammation against foreign 
substances. Silicone is a foreign substance in the body, which will be encapsulated by 
the body. Datia cells (giant cells) will encapsulate silicone material and therefore; 
inflammatory mediators can not perform phagocytosis, which result in continuous 
inflammation and causes side effect.The encapsulated material has poor 
vascularization; therefore it may potentially induce infections.8 
  
Classification and Etiology  
There are many kinds of granuloma classification; however, the common 
classifications are those which have been adjusted to the etiologies.9,10 Granuloma 
formation may occur due to various factors such as biologic, chemical and physical 
irritative agents.9 Classification based on clinical, ethiological, histopathological 
features can be categorized further into infection, vasculitis, immunological 
aberration, leukocyte oxidation deficiency, hypersensitivity, chemicals or 
neoplasma.11,12 Table 2.2 presents classification of granuloma based on etiology.10  
Table 1 Classification of granulomatous disorders (Cited from: James DG, Wiliams WL).10 
==========================================================
==== 
Infections    Immunological aberrasion  
==========================================================
==== 
Fungi    Sarcoidosis 
Histoplasma    Crohn’s disease 
Coccidioides    Phimary billiary cirrhoris 
Blastomyces    Glant cell arteritis 
Sporothrix    Peyronie’s disease 
Aspergillus    Hypogammagiobulinaemia 
Cryptococcus    Langerhans’ granulomatosis 
     Hepatic granulomatous disease 
Protozoa         
Interferon-8-receptor deficiency Immune complex disease 
Toxoplasma 
Leishmania 
     Vasculitic granulomatosis 
Metazoa    Wegener’s 
Toxocara    Necrotizing sarcoidal 
Schistosoma    Churg-Strauss 
     Lymphomatoid 
Sprirochaetes    Polyarteritis nodosa 
T.Pailidum    Bronchocentric 
T.carateum    Systemic lupus 
T.pertunue    
 
     Leukocyte cocidase defect 
Mycobacteria    Chonic granulomatous 
M. tuberculosis   disease of childhood 
M. leprae 
M. kansasil    Hypersensitivity pneumonitis 
M. marinum    Farmers’ lung 
M. avian    Bird fanciers’ 
BOG vaccine    Mushroom workers’ 
     Suberosis (cork dust) 
Bacteria    Bagassosis 
Brucella    Marple bark strippers’ 
Yersinia    Paprika splitters’ 
     Coffee bean 
                                                            Spatlese lung 
Other infections  
Cat-scratch 
Lymphogranuloma   Other 
     Fibrosing alveolitis 
Neoplasia               Whipple’s disease 
Carcinoma    Pyrexia of unknown origin 
Reticulosis    Radiotherapy 
Pinealoma    Cancer chemotherapy 
Dysgerminoma   Panniculitis 
Seminoma    Chalazion 
Reticulum cell sarcoma  Sebacous cyst 
Reticulum cell sarcoma  Dermoid 
Malignant nasal granuloma  Sea urchin spine injury 
     Tattoo 
Chemicals               Malakoplakia 
Beryilium    Blau’s syndrome 
Zirconium 
Silica 
Starch  
 
Silicone granuloma  
Silicone granuloma is a foreign-body granuloma, which is characterized by the 
presence of multinuclear datia cells and marcrophages surrounded by lymphocytes 
and infiltrates of neutrophyls. The granulomatous histological lesion caused by 
silicone varies depending on the type of silicone.  
Tissue reactions to silicone gel or liquids is characterized by the formation of 
silicone granuloma with cystic space containing foreign body.13  The irregular surface 
of silicone can not be phagocytosed completely by macrophage. Datia cells are formed 
due to “frustrated” macrophages. Microspheres in the size of less than 15 microns will 
be phagocytosed and transferred to lymph node; while those with big size and non-
absorbable polymer will be encapsulated by fibrotic tissue.14 
 
       
Figure 2. Results of histopathological examination (HE 400x magnification) in one of study subject. 
There is a datia cell (arrow), which is phagocytosing silicone (S) and is trying to destruct it into smaller 
pieces (sk).1 
Datia cell is essential in tissue response to silicone as seen in figure 2, in 
which the datia cell is phagocytosing the silicone. It appears that although the datia 
cell can not eliminate the silicone, but it would produce fragmented silicone into 
smaller pieces. Within a month, the silicone will be in the size of 20-100 microns.15 
However, it still can not be completely phagocytosed and ultimately it will be 
encapsulated by fibrotic tissue.    
In general, silicone granuloma can be categorized into 3 phases according 
to the natural history of our immune response, which are mild inflammatory 
phase, i.e. stage 1; inflammation with datia cells, i.e. stage 2, 3, 4, 5 and tolerance 
phase with fibrosis, i.e. stage 6 and 7.  
 
According to A Harlim in 2018, histopathological features of silicone granuloma can 
be categorized into 7 stages, which are:15  
Stadium 1, Moderate reaction with a few inflammatory cells  
Stadium 2, Inflammatory cells with one or two datia cell(s)  
Stadium 3, Inflammatory cells with more than two datia cells and < 50% fibrotic area   
sk 
sk 
sk 
S 
S 
S 
 
Stadium 4, Inflammatory cells with more than two datia cells and > 50% fibrotic area  
Stadium 5, Inflammatory cells with one datia cell and > 50% fibrotic area  
Stadium 6, < 50% fibrotic area with no datia cell  
Stadium 7, > 50% fibrotic area with no datia cell 
 
Stadium 1           Stadium 2 
 
Stadium 3 
 
Stadium 4    
 
Stadium 5 
  
 Stadium 6         Stadium 7 
Figure 3. Stadium 1, Moderate reaction with a few inflammatory cells. Stadium 2, Inflammatory cells 
with one or two datia cell(s). Stadium 3, Inflammatory cells with more than two datia cells and < 50% 
fibrotic area. Stadium 4, Inflammatory cells with more than two datia cells and > 50% fibrotic area. 
Stadium 5, Inflammatory cells with one datia cell and > 50% fibrotic area. Stadium 6, < 50% fibrotic 
area with no datia cell. Stadium 7, > 50% fibrotic area with no datia cell. 
 
Diagnosis  
Granuloma is a form of localized nodular inflammation, which is found in 
tissues.9 On examination, there is a tumor-like mass or node of granulation tissue with 
active fibroblast growth and capillaries that contain epithelial-like macrophages 
surrounded by mononuclear cells, lymphocytes, and sometime multinucleated datia 
cells present at the central core of granuloma.16 
On clinical point of view, silicone granuloma is characterized by the presence of 
complications of silicone. There are usually granuloma nodes, migrating silicone, 
wider nose and signs of inflammation such as redness and swelling depending on the 
stage.  
 
Figure 4. Granuloma due to nasal silicone injection. On the photograph, there is 
granuloma node, migrating silicone, the nose becomes wider and signs of 
inflammation such as edema and redness.  
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